EUCTR2013-005429-21-SI进行中（未招募）不适用
Multicentre randomised controlled trials of minimally-invasive surfactanttherapy in preterm infants 25 – 28 weeks gestation on continuouspositive airway pressure.
Menzies Institute of Medical Research, University of Tasmania0 个研究点目标入组 606 人开始时间: 2015年9月2日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 606
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Requiring CPAP or nasal IPPV because of respiratory distress.
- •2. CPAP pressure of 5-8 cm H2O and FiO2 =0.30.
- •3. Less than 6 hours of age.
- •4. Agreement of the Treating Physician in charge of the infant's care.
- •5. Signed parental consent.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 606
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1. Previously intubated, or in imminent need of intubation because of
- •respiratory distress, apnoea or persistent acidosis.
- •2. Congenital anomaly or condition that might adversely affect
- •3. Identifiable alternative cause for respiratory distress (e.g. congenital
- •pneumonia or pulmonary hypoplasia).
- •4. Lack of availability of an OPTIMIST treatment team.
研究者
相似试验
进行中（未招募）
1 期
Premature infants between 25 and 28 weeks gestation may develop lung disease and require respiratory support of continuous positive airway pressure (CPAP). The trial is looking at if there is a benefit from giving a medication called surfactant at an early stage, delivered via a narrow tube briefly placed into the windpipe.EUCTR2013-005429-21-NLMenzies Institute of Medical Research University of Tasmania606
进行中（未招募）
不适用
Premature infants between 25 and 28 weeks gestation may develop lung disease and require respiratory support of continuous positive airway pressure (CPAP). The trial is looking at if there is a benefit from giving a medication called surfactant at an early stage, delivered via a narrow tube briefly placed into the windpipe.Respiratory Distress Syndrome in Premature Babies.EUCTR2013-005429-21-Outside-EU/EEAMenzies Institute of Medical Research University of Tasmania606
进行中（未招募）
1 期
OPTIMIST-A TrialInfant respiratory distress syndrome, also known as hyaline membrane disease.MedDRA version: 18.0Level: LLTClassification code 10020477Term: Hyaline membrane diseaseSystem Organ Class: 100000004855EUCTR2013-005429-21-GBMenzies Research Institute Tasmania606
已完成
不适用
Efficacy and Safety of a Transient Ischaemic Attack (TIA) Electronic Support ToolTransient Ischaemic AttackStroke - IschaemicStrokeACTRN12611000792921Dr Annemarei Ranta40
已完成
不适用
Multicentre randomised controlled trial comparing uterine artery embolisation with surgical treatment for uterine fibroidsterine fibroidsUterine fibroidsCancerISRCTN23023665Greater Glasgow Health Board (North Glasgow University Hospitals Division) (UK)200